Related Experiment Video
Updated: Sep 22, 2025

Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism
Published on: August 19, 2021
Characterization of Glucokinases from Pathogenic Free-Living Amoebae
Jillian E Milanes1, Jimmy Suryadi1, Neil P Monaghan1
1Eukaryotic Pathogens Innovation Center, Department of Genetics and Biochemistry, Clemson Universitygrid.26090.3d, Clemson, South Carolina, USA.
Abstract:
Infection with pathogenic free-living amoebae, including Naegleria fowleri, Acanthamoeba spp., and Balamuthia mandrillaris, can lead to life-threatening illnesses, primarily because of catastrophic central nervous system involvement. Efficacious treatment options for these infections are lacking, and the mortality rate due to infection is high. Previously, we evaluated the N. fowleri glucokinase (NfGlck) as a potential target for therapeutic intervention, as glucose metabolism is critical for in vitro viability. Here, we extended these studies to the glucokinases from two other pathogenic free-living amoebae, including Acanthamoeba castellanii (AcGlck) and B. mandrillaris (BmGlck). While these enzymes are similar (49.3% identical at the amino acid level), they have distinct kinetic properties that distinguish them from each other. For ATP, AcGlck and BmGlck have apparent K values of 472.5 and 41.0 μM, while Homo sapiens Glck (HsGlck) has a value of 310 μM. Both parasite enzymes also have a higher apparent affinity for glucose than the human counterpart, with apparent K values of 45.9 μM (AcGlck) and 124 μM (BmGlck) compared to ~8 mM for HsGlck. Additionally, AcGlck and BmGlck differ from each other and other Glcks in their sensitivity to small molecule inhibitors, suggesting that inhibitors with pan-amoebic activity could be challenging to generate.
Insights
Pathogenic free-living amoebae infections are deadly due to CNS involvement and lack of treatments. This study investigated Acanthamoeba castellanii (AcGlck) and Balamuthia mandrillaris (BmGlck) glucokinases as potential drug targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Parasitology
Background:
- Infections by pathogenic free-living amoebae (FLA) like Naegleria fowleri, Acanthamoeba spp., and Balamuthia mandrillaris cause severe central nervous system disease.
- Current treatments for FLA infections are limited, leading to high mortality rates.
- Targeting essential metabolic pathways, such as glucose metabolism, presents a potential therapeutic strategy.
Purpose of the Study:
- To characterize the glucokinase enzymes from Acanthamoeba castellanii (AcGlck) and Balamuthia mandrillaris (BmGlck).
- To compare the kinetic properties of AcGlck and BmGlck with each other and with human glucokinase (HsGlck).
- To assess the potential of AcGlck and BmGlck as targets for novel anti-amoebic therapies.
Main Methods:
- Enzyme kinetics assays were performed to determine kinetic parameters (Km values) for ATP and glucose.
- Apparent Km values for ATP and glucose were measured for AcGlck, BmGlck, and HsGlck.
- Sensitivity of AcGlck and BmGlck to small molecule inhibitors was evaluated.
Main Results:
- AcGlck and BmGlck share 49.3% amino acid identity but exhibit distinct kinetic properties.
- Both AcGlck and BmGlck have significantly higher apparent affinity for glucose compared to HsGlck.
- AcGlck and BmGlck show differential sensitivity to small molecule inhibitors, complicating the development of pan-amoebic drugs.
Conclusions:
- Glucokinases from Acanthamoeba and Balamuthia are viable targets for anti-amoebic drug development.
- Differences in kinetic properties and inhibitor sensitivity between AcGlck, BmGlck, and HsGlck offer opportunities for selective targeting.
- Developing inhibitors with broad activity against multiple FLA glucokinases may be challenging due to enzyme variations.
Related Concept Videos
Diversity of Protists I
Diversity of Protists IV
Fungal Phylum Microsporidia
cAMP-dependent Protein Kinase Pathways

